Assignee
DENDREON CORP
US43 patents
Top patents by PatentIndex Score
US7012066B2Mar 14, 2006
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP176 citations98
US7244721B2Jul 17, 2007
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP80 citations97
US7169760B2Jan 30, 2007
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP88 citations97
US6080409AJun 27, 2000
Immunostimulatory method
DENDREON CORP152 citations97
US6416958B2Jul 9, 2002
Selective apoptosis of neoplastic cells by an HLA-DR specific monoclonal antibody
DENDREON CORP79 citations96
US6210662B1Apr 3, 2001
Immunostimulatory composition
DENDREON CORP47 citations94
US5976546ANov 2, 1999
Immunostimulatory compositions
DENDREON CORP58 citations94
US7329640B2Feb 12, 2008
Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor
DENDREON CORP16 citations92
US6194152B1Feb 27, 2001
Prostate tumor polynucleotide compositions and methods of detection thereof
DENDREON CORP53 citations92
US7700341B2Apr 20, 2010
Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
DENDREON CORP18 citations91
US7414108B2Aug 19, 2008
Composition and method for producing an immune response against tumor-related antigens
DENDREON CORP29 citations91
US6197579B1Mar 6, 2001
Cell washing device and method
DENDREON CORP42 citations89
US6015843AJan 18, 2000
Process for making silanized colloidal silica
DENDREON CORP22 citations89
US5789148AAug 4, 1998
Cell separation composition
DENDREON CORP26 citations89
US7172892B2Feb 6, 2007
Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon
DENDREON CORP11 citations83
US7112430B2Sep 26, 2006
Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
DENDREON CORP11 citations83
US7597894B2Oct 6, 2009
Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
DENDREON CORP10 citations79
US7132398B2Nov 7, 2006
Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor
DENDREON CORP7 citations73
US7125703B2Oct 24, 2006
Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
DENDREON CORP6 citations73
US7105333B2Sep 12, 2006
Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
DENDREON CORP6 citations73
US7060279B2Jun 13, 2006
Compositions and methods for dendritic cell-based immunotherapy
DENDREON CORP10 citations71
US6121044ASep 19, 2000
Potent antigen presenting cell composition
DENDREON CORP16 citations70
US7276364B1Oct 2, 2007
Nucleic acids encoding endotheliases, endotheliases and uses thereof
DENDREON CORP2 citations62
US6962795B1Nov 8, 2005
Neutrophil inhibitors
DENDREON CORP1 citations62
US5998599ADec 7, 1999
Growth arrest gene compositions and methods
DENDREON CORP4 citations62
US8362264B2Jan 29, 2013
Compositions and methods for the treatment of disease associated with Trp-p8 expression
DENDREON CORP2 citations60
US7772266B2Aug 10, 2010
Small-molecule modulators of TRP-P8 activity
DENDREON CORP3 citations60
US7741355B2Jun 22, 2010
Small-molecule modulators of TRP-p8 activity
DENDREON CORP2 citations60
US7019019B2Mar 28, 2006
Matriptase inhibitors and methods of use
DENDREON CORP6 citations59
US6787612B1Sep 7, 2004
Resin derivatization method and uses thereof
DENDREON CORP4 citations55
US7413869B2Aug 19, 2008
Method for determining potency of antigenic presenting cell based vaccines
DENDREON CORP2 citations52
US7888092B2Feb 15, 2011
Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
DENDREON CORP1 citations51
US7659117B2Feb 9, 2010
Compositions and methods for dendritic cell-based immunotherapy
DENDREON CORP1 citations49
US7560104B2Jul 14, 2009
Compositions and methods for enhancement of major histocompatibility complex class I restricted antigen presentation
DENDREON CORP0 citations46
US7157596B2Jan 2, 2007
Inhibitors of serine protease activity of matriptase or MTSP1
DENDREON CORP2 citations46
US7148324B1Dec 12, 2006
Compositions and methods for enhancement of major histocompatibility complex class I restricted antigen presentation
DENDREON CORP1 citations46
US8647865B2Feb 11, 2014
Promiscuous PAP CD4 T cell epitopes
DENDREON CORP0 citations45
US8361479B2Jan 29, 2013
Promiscuous PAP CD4 T cell epitopes
DENDREON CORP0 citations45
US7972602B2Jul 5, 2011
Promiscuous HER-2/Neu CD4 T cell epitopes
DENDREON CORP0 citations45
US8354507B2Jan 15, 2013
HLA-DR specific antibodies, compositions and methods
DENDREON CORP0 citations42
US7279309B2Oct 9, 2007
Process for manufacture of Nematode-extracted Anticoagulant Protein (NAP)
DENDREON CORP0 citations38
US7262211B2Aug 28, 2007
Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation
DENDREON CORP0 citations38
US10261091B2Apr 16, 2019
Humoral immune response against tumor antigens after treatment with a cancer antigen specific active immunotherapy and its association with improved clinical outcome
DENDREON CORP0 citations30